Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Advances and Novel Treatment Options in Metastatic Melanoma
| Advances and Novel Treatment Options in Metastatic Melanoma |
| Autore | Facchiano Antonio |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (528 p.) |
| Soggetto topico | Medicine and Nursing |
| Soggetto non controllato |
ABT-737
acetazolamide acetylcholine adjuvant therapy amoeboid motility angiogenesis apoptosis arthralgia Bcl-2 family BCL2L10 biomarkers BRAF BRAF inhibitor BRAF inhibitors BRAF-mutant melanoma cancer cancer associated fibroblast cancer stem cells carbonic anhydrase cell therapy checkpoint inhibitor cholinergic system combined therapy ctDNA CXCL10 cyclopamine cytokines cytotoxicity diagnosis DOCK4 drug resistance essential oils exosomes extracellular vesicles FAK hedgehog HIPPO HuR immunity immunotherapy interferon invasion ipilimumab lactate dehydrogenase lipid metabolism liquid biopsy liver-directed-therapies machine learning MANS peptide MARCKS mechanism of action melanoma melanoma immune infiltrate melanoma markers melanoma metastasis melanoma PDX melanomagenesis metalloproteinases metastases metastasis metastatic dormancy metastatic therapy metastatic uveal melanoma (mUM) microenvironment microRNAs MITF ML258 motility mucosal melanoma muscarinic receptors n/a nanoparticles nicotinic receptors nivolumab OXPHOS patient stratification PD-1 pembrolizumab phosphorylation plasmacytoid dendritic cells prediction principal component analysis prognosis prognostication protein tyrosine phosphatase PTPs inhibitors Rac1 radiotherapy resistance rheumatoid arthritis sex-hormones sex/gender ShcD adaptor protein siRNA slow cycling phenotype small molecules SOCE STAT3 Support Vector Machine survival target therapy targeted therapy targeted-therapy therapeutic resistance therapy TLR TPC2 tumor microenvironment tumour microenvironment uveal melanoma (UM) WNT5A |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557612103321 |
Facchiano Antonio
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advances in Diagnosis and Therapy of Neuroendocrine Neoplasms
| Advances in Diagnosis and Therapy of Neuroendocrine Neoplasms |
| Autore | Segelov Eva |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (144 p.) |
| Soggetto topico | Medicine and Nursing |
| Soggetto non controllato |
2017 WHO classification
2019 WHO classification body mass index cancer care cancer-driven genes carcinoid heart disease carcinoid syndrome chemotherapy CommNETs curative surgery diabetes mellitus follow-up germline mutations grading guidelines liver metastases long-term functional outcomes malignant castration-resistant prostatic cells management MANEC medullary thyroid carcinoma meta-analysis metastases metronomic treatment midgut MiNENs mixed adeno-neuroendocrine carcinoma mixed non-neuroendocrine neuroendocrine neoplasms modified Delphi multidisciplinary mutational mechanism NETs neuroendocrine neoplasms neuroendocrine tumor neuroendocrine tumors neuroendocrine tumour neuroendocrine tumours NOTCH outcome pancreatectomy pancreatic exocrine insufficiency pancreatic NET pancreatic neuroendocrine neoplasms pancreatic neuroendocrine tumours parenchyma-sparing surgery QPIs quality performance indicators recurrence relapse resection risk factor second-line small bowel NET small bowel neuroendocrine tumours small cell lung carcinoma somatostatin analogues staging temozolomide |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557692903321 |
|
Segelov Eva
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Redox-Active Molecules as Therapeutic Agents
| Redox-Active Molecules as Therapeutic Agents |
| Autore | Fernandes Ana Sofia |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (266 p.) |
| Soggetto topico |
Biology, life sciences
Research and information: general |
| Soggetto non controllato |
(poly)phenols
adipose-derived mesenchymal stem cell amniotic membrane-derived mesenchymal stem cell antioxidant capacity antioxidants apoptosis apurinic/apyrimidinic endonuclease 1 assisted reproductive technology ATF4 BAPN bioactivity-based assays breast cancer cancer therapy cardiorenal syndrome carnosic acid CD IGS rats cell cycle cell invasion chemoresistance cisplatin conditioned medium curcumin cyanidin Cysteamine cytotoxicity DNA damage doxorubicin E3330 embryo EMT glutathione peroxidase glutathione reductase GSH H2S donors hydrogen sulfide hypercholesterolemia in vitro culture in vitro fertilization inhibitors invasion KEAP1 lactic acid bacteria lysyl-oxidase lysyl-oxidase like 2 metabolomics metastases migration mitochondrial reactive oxygen species N-acetyl cysteine n/a non-small cell lung cancer NRF2 nuclear factor erythroid 2-related factor 2 (Nrf2) oxidative stress OxPhos peroxiredoxin 3 pro-oxidant therapy prostate cancer reactive oxygen species redox signaling Rubus genus selenium-enriched Enterococcus faecium selenium-enriched Streptococcus thermophilus SGK1 sildenafil systemic sclerosis thiostrepton thiosulfate verbascoside withanolide yeast-based discovery platform |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910580213403321 |
|
Fernandes Ana Sofia
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Role of MicroRNA in Cancer Development and Treatment
| Role of MicroRNA in Cancer Development and Treatment |
| Autore | Pulliero Alessandra |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (280 p.) |
| Soggetto topico |
Medicine and Nursing
Pharmacology |
| Soggetto non controllato |
air pollution
angiogenesis asbestos asbestos exposure biomarker biomarkers breast cancer cancer cancer prevention cancer stem cells carcinogenesis chemoresistance cutaneous tissues diagnosis DNA adducts early diagnosis early disease prevention environmental pollutants environmental risk factors epigenetic modulations epigenetics exposure extracellular vesicles fluoro-edenite genetic and microbiome markers genetic polymorphisms glioblastoma health technology assessment human in vitro study liquid biopsy lung cancer malignant mesothelioma mesothelioma metastases microbiota microRNA microRNAs miR-625 miRNA miRNAs mutations MYCN amplification n/a neuroblastoma no-smokers lung cancer nonsmokers lung cancer oncogenes oral squamous cell carcinoma ozone exposure plasticizers PRISMA prognosis public health genomics qPCR saliva |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910576878603321 |
|
Pulliero Alessandra
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||